Highland Capital Management, a well-known global alternative credit specialist, recently raised capital commitments amounting to $147 million for its Asian healthcare-focused private equity fund. According to the company, the anchor investor was the National Pension Service of South Korea. In Asia, Highland Capital Management will work with a Korean venture capital and private equity firm by the name of Stonebridge Capital. The firm will also act as the fund’s co-manager. The fund’s principal investment targets will be North American and Asian middle market healthcare companies. Learn more about Highland Capital at Affiliate Dork.
Over the last two years, Asian investors have increasingly shown interest in the industry. However, most of the investments made were through multi-purpose funds or direct basis. In addition to returns on investment, investors taking part in the National Pension Service Korea fund with Highland have specific intentions in the healthcare industry. Some of these aims include admittance to co-investment opportunities to serve their projected goals in the U.S., China, and Korea. According to the co-head and managing director of Highland Capital Management’s private equity group Carl Moore, the strategy of the fund is in line with the company’s core abilities drawn from Highland’s broad experience in the healthcare industry. Presently, Highland has healthcare assets worth more than $1.5 billion under management. Additionally, it has investment capital worth more than $1.4 billion across its PE business.
More about Highland Capital Management
Mark Okada and Jim Dondero founded Highland in 1993. The company focuses on credit strategies, including collateral loan obligations, credit hedge funds, and special and distressed situation private equity. Additionally, Highland Capital provides alternative investments, such as natural resources, long and short equities, and emerging markets. According to the co-head and managing director of Highland Capital Management Matt Jameson, the healthcare sector in the United States faces several disruptive forces that affect middle market companies acutely. He adds that increasing the access to healthcare services has helped drive greater levels of utilization and more complex government and consumer demands in Asia. These factors together with the expansion to reimbursement models based on value help create considerable opportunities for investors in the healthcare industry. Read more at bloomberg.com.